Veeva Systems Inc. (VEEV)
| Market Cap | 44.80B -4.3% |
| Revenue (ttm) | 3.46B +16.5% |
| Net Income | 1.01B +25.3% |
| EPS | 6.10 +25.5% |
| Shares Out | 161.91M |
| PE Ratio | 45.36 |
| Forward PE | 28.68 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 3,642,283 |
| Open | 280.00 |
| Previous Close | 282.13 |
| Day's Range | 276.45 - 284.68 |
| 52-Week Range | 148.05 - 310.50 |
| Beta | 0.92 |
| Analysts | Buy |
| Price Target | 294.07 (+6.28%) |
| Earnings Date | Aug 26, 2026 |
About VEEV
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud comprising Veeva Vault CRM Suite for pharmaceutical and biotechnology companies; Veeva Medical that provides source of medical content across multiple channels and geographies; Veeva PromoMats, an end-to-end content and digital asset management solution; and Veeva Crossix, an analytics platform for pharmaceutical brands. It also provides ... [Read more]
Financial Performance
In fiscal year 2026, Veeva Systems's revenue was $3.20 billion, an increase of 16.34% compared to the previous year's $2.75 billion. Earnings were $908.91 million, an increase of 27.27%.
Financial StatementsAnalyst Summary
According to 28 analysts, the average rating for VEEV stock is "Buy." The 12-month stock price target is $294.07, which is an increase of 6.28% from the latest price.
News
Veeva Systems Stock Is Having Its Best Day Ever as Software Sector Rallies
Veeva Systems stock surges and is having its best day ever after the software company's quarterly earnings and guidance made Wall Street believers.
Veeva Systems Earnings Call Transcript: Q2 2027
Q2 revenue and operating income exceeded guidance, driven by record commercial and CRM performance, strong AI momentum with Falcon, and continued growth in R&D and data products. Updated FY 2027 guidance reflects confidence in long-term growth, with new product adoption and strategic wins in top biopharma accounts.
Veeva Systems Earnings release: Q2 2027
Veeva Systems released its Q2 2027 earnings on August 26, 2026, summarizing the period's financial results.
Veeva Systems Slides: Q2 2027
Veeva Systems has posted slides in relation to its Q2 2027 quarterly earnings report, which was published on August 26, 2026.
Veeva Systems Quarterly report: Q2 2027
Veeva Systems has published its Q2 2027 quarterly earnings report on August 26, 2026.
Veeva Announces Fiscal 2027 Second Quarter Results
Total Revenues of $928.0M, up 18% Year Over Year Subscription Revenues of $766.8M, up 16% Year Over Year PLEASANTON, Calif., Aug. 26, 2026 /PRNewswire/ -- Veeva Systems Inc. (NYSE: VEEV), a leading pr...
Veeva Vault CRM Selected by Biogen
Unified commercial platform to help speed the delivery of medicines to patients PLEASANTON, Calif., Aug. 25, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Biogen has committed t...
Veeva Vault CRM Selected by Regeneron
Leading biopharma company selects agentic CRM for life sciences to generate Commercial Evidence PLEASANTON, Calif., Aug. 25, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Regen...
Veeva Vault CRM Selected by Eli Lilly and Company
PLEASANTON, Calif., Aug. 11, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Eli Lilly and Company (Lilly) has committed to Veeva Vault CRM globally.
Veeva to Release Fiscal 2027 Second Quarter Results on August 26, 2026
PLEASANTON, Calif., Aug. 5, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) will announce financial results for its second quarter ending July 31, 2026 after market close on August 26, 2026.
Veeva Introduces New EHS Application for Proactive Risk Management and Intelligent Automation
Environmental, health, and safety solution is part of Veeva Quality Cloud and will deliver real-time insights and streamlined workflows PLEASANTON, Calif., June 25, 2026 /PRNewswire/ -- Veeva Systems ...
Veeva Acquires Copli, Launches Veeva Falcon MLR to Accelerate Content Review
Now Available, Veeva Falcon MLR Delivers Agentic MLR TM to Significantly Reduce Manual Effort and Shorten Review Cycles PLEASANTON, Calif. and COPENHAGEN, Denmark, June 23, 2026 /PRNewswire/ -- Veeva...
Veeva Systems Transcript: AGM 2026
The meeting covered director elections and auditor ratification, with no additional proposals or shareholder questions. Voting was conducted online, and results will be filed publicly on Form 8-K.
UCB Unifies Global Pharmacovigilance Operations with Veeva Safety Suite
End-to-end safety foundation to speed case processing and enable automation PLEASANTON, Calif., June 9, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that UCB is unifying its global ...
Veeva Systems Earnings Call Transcript: Q1 2027
Revenue and operating income exceeded guidance, driven by strong execution in AI, CRM, and Crossix. Ostro acquisition and Falcon AI platform signal continued innovation, while guidance remains conservative amid early-stage scaling of key R&D products.
Veeva Systems Earnings release: Q1 2027
Veeva Systems released its Q1 2027 earnings on June 3, 2026, summarizing the period's financial results.
Veeva Systems Slides: Q1 2027
Veeva Systems has posted slides in relation to its Q1 2027 quarterly earnings report, which was published on June 3, 2026.
Veeva Systems Quarterly report: Q1 2027
Veeva Systems has published its Q1 2027 quarterly earnings report on June 3, 2026.
Veeva Announces Fiscal 2027 First Quarter Results
Total Revenues of $882.9M, up 16% Year Over Year Subscription Revenues of $730.2M, up 15% Year Over Year PLEASANTON, Calif., June 3, 2026 /PRNewswire/ -- Veeva Systems Inc. (NYSE: VEEV), a leading pro...
Veeva Quality Cloud Advances Manufacturing Operations for Kindeva
Global CDMO will unify sites on single quality platform for greater efficiency and scalability PLEASANTON, Calif., May 28, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Kindeva is ad...
Teva Pharmaceuticals Commits to Veeva Vault CRM
Agentic CRM with industry-specific AI for deeper customer engagement PLEASANTON, Calif., May 27, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Teva Pharmaceuticals has committed...
Veeva Announces Falcon, an Agentic Platform and Standard Agents to Deliver Agentic Labor in Drug Development
Veeva Falcon works with Veeva clinical, regulatory, and safety applications to increase speed and lower costs PLEASANTON, Calif., May 27, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announce...
Merck KGaA, Darmstadt, Germany Selects Veeva Vault CRM Worldwide
Agentic CRM with deep industry-specific capabilities provides commercial foundation for the future PLEASANTON, Calif., May 27, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Merc...
Veeva Commercial Summit to Feature Biopharma's AI Successes and the Path to Agentic Commercial
argenx, Bayer, Boehringer Ingelheim, Genentech, Gilead, GSK, Merck, Novo Nordisk, Takeda, and Vertex share how they are redefining engagement across sales, marketing, and medical PLEASANTON, Calif., M...
Veeva to Release Fiscal 2027 First Quarter Results on June 3, 2026
PLEASANTON, Calif., May 13, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) will announce financial results for its first quarter ending April 30, 2026 after market close on June 3, 2026.